<?xml version="1.0" encoding="UTF-8"?>
<p>Following experience with the successful clinical trials of the H5N2 live-attenuated influenza vaccine and obtaining the licensure for its pandemic use from the Thai FDA, the GPO is conducting clinical trials and scaling up the production of IIVs.</p>
